IHE ETF
iShares US Pharmaceutical ETF
LLY is IHE's largest holding at 26.88% of the fund as of Nov 3, 2026. IHE is iShares US Pharmaceutical ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | L | Eli Lilly & CoHealth Care · Pharmaceuticals | 26.88% | 26.9% | 1,417 | $436.55M | Health Care | Pharmaceuticals |
| 2 | J | Johnson & Johnson -Health Care · Pharmaceuticals | 21.80% | 48.7% | 273 | $354.16M | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | R | Royalty Pharma | 4.73% | 53.4% | 67 | $76.78M | ||
| 4 | P | Pfizer Inc | 4.68% | 58.1% | 30 | $76.07M | ||
| 5 | Z | Zoetis Inc Class A | 4.64% | 62.7% | 79 | $75.30M | ||
| 6 | V | Viatris Inc | 4.56% | 67.3% | 19 | $74.14M | ||
| 7 | M | Merck & Company Inc | 4.32% | 71.6% | 149 | $70.18M | ||
| 8 | B | Bristol-Myers Squibb Co | 4.14% | 75.7% | 62 | $67.17M | ||
| 9 | J | Jazz Pharmaceuticals PLC | 2.93% | 78.7% | 215 | $47.54M | ||
| 10 | E | Elanco Animal Health Inc | 2.41% | 81.1% | 23 | $39.07M | ||
| 11 | C | Corcept Therapeutics Inc | 1.61% | 82.7% | 81 | $26.17M | ||
| 12 | A | Axsome Therapeutics Inc | 1.34% | 84.0% | 144 | $21.81M | ||
| 13 | L | Ligand Pharmaceuticals Inc | 1.34% | 85.4% | 322 | $21.82M | ||
| 14 | — | Definium Therapeutics Inc | 1.02% | 86.4% | 36 | $16.55M | ||
| 15 | M | Veradermics Inc | 0.91% | 87.3% | 139 | $14.84M | ||
| 16 | — | Indivior Pharmaceuticals Inc | 0.87% | 88.2% | 35 | $14.15M | ||
| 17 | A | Amneal Pharmaceuticals Inc Class A | 0.83% | 89.0% | 21 | $13.46M | ||
| 18 | O | Organon & Co | 0.76% | 89.8% | 13 | $12.32M | ||
| 19 | — | Liquidia Technologies Inc | 0.70% | 90.5% | 45 | $11.35M | ||
| 20 | E | Edgewise Therapeutics Inc | 0.66% | 91.1% | 38 | $10.74M | ||
| 21 | A | Amylyx Pharmaceuticals Inc | 0.62% | 91.8% | 28 | $10.07M | ||
| 22 | T | Tarsus Pharmaceuticals Inc | 0.60% | 92.3% | 74 | $9.80M | ||
| 23 | E | Enliven Therapeutics Inc | 0.59% | 92.9% | 44 | $9.56M | ||
| 24 | S | Supernus Pharmaceuticals Inc | 0.51% | 93.5% | 41 | $8.24M | ||
| 25 | P | Prestige Consumer Healthcare Inc | 0.49% | 93.9% | 49 | $7.88M | ||
| 26 | P | Perrigo Co PLC | 0.46% | 94.4% | 15 | $7.43M | ||
| 27 | X | Xeris Biopharma Holdings Inc | 0.41% | 94.8% | 10 | $6.63M | ||
| 28 | H | Harmony Biosciences Holdings Inc | 0.40% | 95.2% | 38 | $6.51M | ||
| 29 | M | MBX Biosciences Inc | 0.35% | 95.6% | 55 | $5.66M | ||
| 30 | T | Trevi Therapeutics Inc | 0.34% | 95.9% | 13 | $5.51M | ||
| 31 | I | Innoviva Inc | 0.32% | 96.2% | 21 | $5.20M | ||
| 32 | A | ANI Pharmaceuticals Inc | 0.30% | 96.5% | 72 | $4.92M | ||
| 33 | P | Pacira Biosciences Inc | 0.30% | 96.8% | 36 | $4.91M | ||
| 34 | O | Omeros Corp | 0.28% | 97.1% | 18 | $4.52M | ||
| 35 | O | Ocular Therapeutix Inc | 0.27% | 97.4% | 6 | $4.36M | ||
| 36 | N | Nuvation Bio Inc Class A | 0.26% | 97.6% | 4 | $4.26M | ||
| 37 | M | Maze Therapeutics Inc | 0.24% | 97.9% | 31 | $3.91M | ||
| 38 | R | Rapport Therapeutics Inc | 0.23% | 98.1% | 25 | $3.68M | ||
| 39 | S | Septerna Inc | 0.22% | 98.3% | 44 | $3.55M | ||
| 40 | L | LB Pharmaceuticals Inc | 0.21% | 98.5% | 39 | $3.39M | ||
| 41 | H | Harrow Inc | 0.19% | 98.7% | 28 | $3.05M | ||
| 42 | A | Amphastar Pharmaceuticals Inc | 0.18% | 98.9% | 27 | $2.95M | ||
| 43 | P | Phibro Animal Health Corp | 0.17% | 99.1% | 38 | $2.77M | ||
| 44 | C | Collegium Pharmaceutical Inc | 0.16% | 99.2% | 23 | $2.62M | ||
| 45 | A | Alumis Inc | 0.13% | 99.4% | 6 | $2.06M | ||
| 46 | W | Wave Life Sciences Inc | 0.11% | 99.5% | 3 | $1.82M | ||
| 47 | A | Arvinas Inc | 0.10% | 99.6% | 7 | $1.60M | ||
| 48 | A | Avalyn Pharma Inc | 0.09% | 99.7% | 25 | $1.54M | ||
| 49 | E | Evolus Inc | 0.09% | 99.7% | 7 | $1.46M | ||
| 50 | C | Cormedix Inc | 0.08% | 99.8% | 5 | $1.28M | ||
| More holdings · Pro | ||||||||
IHE ETF All Holdings
IHE holdings total 57 positions. The top 10 holdings account for 81.1% of the fund, led by Eli Lilly & Co at 26.9%, Johnson & Johnson - Common at 21.8%, Royalty Pharma at 4.7%.
IHE portfolio concentration is relatively high, with the top 10 representing 81.1% of total assets. The largest sector exposure is Health Care at 90.9%.
IHE sectors provide a detailed breakdown. IHE overlap shows how holdings compare to other funds in your portfolio.
IHE ETF Holdings
57 of 57 holdings
- 1
Eli Lilly & Co
LLYHealth Care26.88% - 2
Johnson & Johnson - Common
JNJHealth Care21.80% - 3
Royalty Pharma
RPRXUnknown4.73% - 4
Pfizer Inc
PFEHealth Care4.68% - 5
Zoetis Inc Class A
ZTSHealth Care4.64% - 6
Viatris Inc
MYLHealth Care4.56% - 7
Merck & Company Inc
MRKHealth Care4.32% - 8
Bristol-Myers Squibb Co
BMYHealth Care4.14% - 9
Jazz Pharmaceuticals PLC
JAZZHealth Care2.93% - 10
Elanco Animal Health Inc
ELANHealth Care2.41% - 11
Corcept Therapeutics Inc
CORTHealth Care1.61% - 12
Axsome Therapeutics Inc
AXSMHealth Care1.34% - 13
Ligand Pharmaceuticals Inc
LGNDHealth Care1.34% - 14
Definium Therapeutics Inc
DFTX:CAUnknown1.02% - 15
Veradermics Inc
MANEUnknown0.91% - 16
Indivior Pharmaceuticals Inc
INDV:MBUnknown0.87% - 17
Amneal Pharmaceuticals Inc Class A
AMRXHealth Care0.83% - 18
Organon & Co
OGNHealth Care0.76% - 19
Liquidia Technologies Inc
LQDAHealth Care0.70% - 20
Edgewise Therapeutics Inc
EWTXHealth Care0.66% - 21
Amylyx Pharmaceuticals Inc
AMLXHealth Care0.62% - 22
Tarsus Pharmaceuticals Inc
TARSHealth Care0.60% - 23
Enliven Therapeutics Inc
ELVNHealth Care0.59% - 24
Supernus Pharmaceuticals Inc
SUPNHealth Care0.51% - 25
Prestige Consumer Healthcare Inc
PBHConsumer Staples0.49% - 26
Perrigo Co PLC
PRGOConsumer Staples0.46% - 27
Xeris Biopharma Holdings Inc
XERSHealth Care0.41% - 28
Harmony Biosciences Holdings Inc
HRMYHealth Care0.40% - 29
MBX Biosciences Inc
MBXHealth Care0.35% - 30
Trevi Therapeutics Inc
TRVIHealth Care0.34% - 31
Innoviva Inc
INVAHealth Care0.32% - 32
ANI Pharmaceuticals Inc
ANIPHealth Care0.30% - 33
Pacira Biosciences Inc
PCRXHealth Care0.30% - 34
Omeros Corp
OMERHealth Care0.28% - 35
Ocular Therapeutix Inc
OCULHealth Care0.27% - 36
Nuvation Bio Inc Class A
NUVBHealth Care0.26% - 37
Maze Therapeutics Inc
MAZEHealth Care0.24% - 38
Rapport Therapeutics Inc
RAPPHealth Care0.23% - 39
Septerna Inc
SEPNHealth Care0.22% - 40
LB Pharmaceuticals Inc
LBRXUnknown0.21% - 41
Harrow Inc
HROWHealth Care0.19% - 42
Amphastar Pharmaceuticals Inc
AMPHHealth Care0.18% - 43
Phibro Animal Health Corp
PAHCHealth Care0.17% - 44
Collegium Pharmaceutical Inc
COLLHealth Care0.16% - 45
Alumis Inc
ALMSIndustrials0.13% - 46
Wave Life Sciences Inc
WVEUnknown0.11% - 47
Arvinas Inc
ARVNHealth Care0.10% - 48
Avalyn Pharma Inc
AVLNUnknown0.09% - 49
Evolus Inc
EOLSHealth Care0.09% - 50
Cormedix Inc
CRMDHealth Care0.08% - 51
Phathom Pharmaceuticals Inc
PHATHealth Care0.07% - 52
USD Cash
Other0.06% - 53
Bioage Labs Inc
BIOAHealth Care0.05% - 54
EyePoint Inc
EYPTHealth Care0.01% - 55
Blackrock Cash Funds: Treasury, Sl Agency Shares
XTSLAFinancials0.00% - 56
Cash Collateral USD Sgaft
Other0.00% - 57
E-Mini Health Care Sector Dec 26
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 26.880% | ||
| 2 | Johnson & Johnson - Common | JNJ | 21.800% | ||
| 3 | Royalty Pharma | RPRX | 4.730% | ||
| 4 | Pfizer Inc | PFE | 4.680% | ||
| 5 | Zoetis Inc Class A | ZTS | 4.640% | ||
| 6 | Viatris Inc | MYL | 4.560% | ||
| 7 | Merck & Company Inc | MRK | 4.320% | ||
| 8 | Bristol-Myers Squibb Co | BMY | 4.140% | ||
| 9 | Jazz Pharmaceuticals PLC | JAZZ | 2.930% | ||
| 10 | Elanco Animal Health Inc | ELAN | 2.410% | ||
| 11 | Corcept Therapeutics Inc | CORT | 1.610% | ||
| 12 | Axsome Therapeutics Inc | AXSM | 1.340% | ||
| 13 | Ligand Pharmaceuticals Inc | LGND | 1.340% | ||
| 14 | Definium Therapeutics Inc | DFTX:CA | 1.020% | ||
| 15 | Veradermics Inc | MANE | 0.910% | ||
| 16 | Indivior Pharmaceuticals Inc | INDV:MB | 0.870% | ||
| 17 | Amneal Pharmaceuticals Inc Class A | AMRX | 0.830% | ||
| 18 | Organon & Co | OGN | 0.760% | ||
| 19 | Liquidia Technologies Inc | LQDA | 0.700% | ||
| 20 | Edgewise Therapeutics Inc | EWTX | 0.660% | ||
| 21 | Amylyx Pharmaceuticals Inc | AMLX | 0.620% | ||
| 22 | Tarsus Pharmaceuticals Inc | TARS | 0.600% | ||
| 23 | Enliven Therapeutics Inc | ELVN | 0.590% | ||
| 24 | Supernus Pharmaceuticals Inc | SUPN | 0.510% | ||
| 25 | Prestige Consumer Healthcare Inc | PBH | 0.490% | ||
| 26 | Perrigo Co PLC | PRGO | 0.460% | ||
| 27 | Xeris Biopharma Holdings Inc | XERS | 0.410% | ||
| 28 | Harmony Biosciences Holdings Inc | HRMY | 0.400% | ||
| 29 | MBX Biosciences Inc | MBX | 0.350% | ||
| 30 | Trevi Therapeutics Inc | TRVI | 0.340% | ||
| 31 | Innoviva Inc | INVA | 0.320% | ||
| 32 | ANI Pharmaceuticals Inc | ANIP | 0.300% | ||
| 33 | Pacira Biosciences Inc | PCRX | 0.300% | ||
| 34 | Omeros Corp | OMER | 0.280% | ||
| 35 | Ocular Therapeutix Inc | OCUL | 0.270% | ||
| 36 | Nuvation Bio Inc Class A | NUVB | 0.260% | ||
| 37 | Maze Therapeutics Inc | MAZE | 0.240% | ||
| 38 | Rapport Therapeutics Inc | RAPP | 0.230% | ||
| 39 | Septerna Inc | SEPN | 0.220% | ||
| 40 | LB Pharmaceuticals Inc | LBRX | 0.210% | ||
| 41 | Harrow Inc | HROW | 0.190% | ||
| 42 | Amphastar Pharmaceuticals Inc | AMPH | 0.180% | ||
| 43 | Phibro Animal Health Corp | PAHC | 0.170% | ||
| 44 | Collegium Pharmaceutical Inc | COLL | 0.160% | ||
| 45 | Alumis Inc | ALMS | 0.130% | ||
| 46 | Wave Life Sciences Inc | WVE | 0.110% | ||
| 47 | Arvinas Inc | ARVN | 0.100% | ||
| 48 | Avalyn Pharma Inc | AVLN | 0.090% | ||
| 49 | Evolus Inc | EOLS | 0.090% | ||
| 50 | Cormedix Inc | CRMD | 0.080% | ||
| 51 | Phathom Pharmaceuticals Inc | PHAT | 0.070% | ||
| 52 | USD Cash | - | 0.060% | ||
| 53 | Bioage Labs Inc | BIOA | 0.050% | ||
| 54 | EyePoint Inc | EYPT | 0.010% | ||
| 55 | Blackrock Cash Funds: Treasury, Sl Agency Shares | XTSLA | 0.000% | ||
| 56 | Cash Collateral USD Sgaft | - | 0.000% | ||
| 57 | E-Mini Health Care Sector Dec 26 | - | 0.000% |














































